172 related articles for article (PubMed ID: 37863562)
1. Lymphomas and Amyloid in the Gastrointestinal Tract.
Ware AD; Wake LM; Fedoriw Y
Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
3. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
Owens SR
Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative Disorders of the Gastrointestinal Tract.
Skinnider BF
Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
[TBL] [Abstract][Full Text] [Related]
6. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
7. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
Alves de Castro JV; Costa FD; Ferreira CR
Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
9. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
10. Update on Gastrointestinal Lymphomas.
Weindorf SC; Smith LB; Owens SR
Arch Pathol Lab Med; 2018 Nov; 142(11):1347-1351. PubMed ID: 30407861
[TBL] [Abstract][Full Text] [Related]
11. The recognition and classification of lymphoproliferative disorders of the gut.
O'Malley DP; Goldstein NS; Banks PM
Hum Pathol; 2014 May; 45(5):899-916. PubMed ID: 24613566
[TBL] [Abstract][Full Text] [Related]
12. Extranodal T- and NK-cell lymphomas.
de Leval L; Feldman AL; Pileri S; Nakamura S; Gaulard P
Virchows Arch; 2023 Jan; 482(1):245-264. PubMed ID: 36336765
[TBL] [Abstract][Full Text] [Related]
13. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Oishi N; Ahmed R; Feldman AL
Curr Hematol Malig Rep; 2023 Dec; 18(6):252-263. PubMed ID: 37870698
[TBL] [Abstract][Full Text] [Related]
14. Recent advances upper gastrointestinal lymphomas: molecular updates and diagnostic implications.
Foukas PG; Bisig B; de Leval L
Histopathology; 2021 Jan; 78(1):187-214. PubMed ID: 33382495
[TBL] [Abstract][Full Text] [Related]
15. Overview of Gastrointestinal Lymphoproliferative disorders
Auerbach A; Aguilera NS
Semin Diagn Pathol; 2021 Jul; 38(4):1-5. PubMed ID: 33714627
[TBL] [Abstract][Full Text] [Related]
16. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
17. Lymph node involvement by enteropathy-like indolent NK-cell proliferation.
Dargent JL; Tinton N; Trimech M; de Leval L
Virchows Arch; 2021 Jun; 478(6):1197-1202. PubMed ID: 32696224
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and molecular features of indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.
Yi H; Li A; Ouyang B; Da Q; Dong L; Liu Y; Xu H; Zhang X; Zhang W; Jin X; Gu Y; Wang Y; Liu Z; Wang C
Histopathology; 2023 Mar; 82(4):567-575. PubMed ID: 36494712
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.
Mannami T; Yoshino T; Oshima K; Takase S; Kondo E; Ohara N; Nakagawa H; Ohtsuki H; Harada M; Akagi T
Mod Pathol; 2001 Jul; 14(7):641-9. PubMed ID: 11454995
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
Burke JS
Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]